, , ,

<<


 >>  ()
Pages:     | 1 | 2 || 4 |

...

-- [ 3 ] --

-, m/z (I. (%)): 198.05[M]+ (100), 199 (69), 182 (12), 171 (31), 157 (8), 115 (9), (10), 51 (5).

65% , 2- -3,8 . 110-111C/0.2 .. 13 (, (33) ..): 14.62 ((H2)2CH3), 15.21 (H2CH3), 15. (H2CH3), 21.62 (H2H2CH3), 24.24 (H2CH3), H C 24.70 (H2CH3), 37.34 (H2H2CH3), 124.83 (C7), CH 125.34 (C5), 126.25 (C4), 126.62 (C6), 127.22 (C4), (CH2)2CH N 133.66 (C8), 134.99 (C3), 142.50 (C8a), 160.01 (C2).

H2C CH 1H (CDCl3,, ..): 1.02 (3H, CH3, J 8 ), 1.12 (3H, CH3, J 7.2 ), 1.38 (3H, CH3, J 7.6 ), 1.90-2.05 (2H, CH2CH2CH3), 2.85 (2, H2CH3, J 7.6 ), 2.89 (2, H2CH3, J 7.6 ), 3.19 (2, CH2CH2CH3, J ), 7.39 (1H, 6H, J 7.6 ), 7.44 (1H, 7H, J 7.6 ), 7.54 (1H, 5H, J 6.8 ), 7.80 (1H, 4H).

64%. . 65-68C. (, 2--8- ..): 25.19 (3), 122.84 (C3), 125.45(C6), 126. (34) (C4), 127.37 (C5), 128.80 (C7), 130.13 (C8), 137. (C4), 148.56 (C8a), 161.87 (C2). 1H (CDCl3,, ..): 2.84 (3H,CH3), 7.38-7.50 (1H, CH N Cl 3,6H), 7.82 (1H, 7H, J 7.6 ), 8.00 (1H, 4H, J 8.4 ), 8.03 (1H, 5H, J 8 ). , m/z (I. (%)): 177. 1[M]+.

70%. . 92-95oC/0.3 .. 3--8--2- (, ..): 12.28 (H2CH3), 18.92 (3), (35) 29.74 (CH2CH3), 125.39 (C6), 129.15 (C5), 132. (C4), 125.87 (C7), 128.52 (C3), 130.55 (C8), 135. CH (C4), 143.99 (C8a), 163.89 (C2). 1H CH C N (CDCl3,, ..): 1.39 (3H, CH3, J 7 ), 2.47 c H Cl (3, CH3), 3.00 (2, CH2, J 7.6 ), 7.30 (1H, 6H, J 7.6 ), 7.57 (1H, 7H, J 7.6 ), 7.70 (1H, 5H, J 7.2 ), 7.77 (1H, 4H). , m/z (I. (%)): 203.95[M]+ (100), 205 (63), 206 (38), 177 (25), 140 (18), 115 (18), 63 (10).

72% , 2--8--3 . 92-93C/0.35 .. (, (36) ..): 19.01 ((H2)2CH3), 19.20 (H2CH3), 26. H (H2H2CH3), C 30.10 (H2CH3), 42. CH (H2H2CH3), 130.11 (C7), 130.45 (C5), 130. (CH2)2CH N (C8), 131.84 (C6), 133.12 (C4a), 132.22 (C4), 138. Cl (C3), 150.55 (C8a), 170.13 (C2). 1H (CDCl3,, ..): 1.02 (3H, CH3, J 7.6 ), 1.18 ), (3H, CH3, J 7.6 1.90-2.00 (2H, CH2CH2CH3), 2.61 (2, H2CH3, J 7.6 ), 2. (2, CH2CH2CH3, J 8 ), 7.16 (1H, 7H, J 7. ), 7.43 (1H, 6H, J 7.2 ), 7.55 (1H, 5H, J 7.6 ), 7.60 (1H, 4H). -, m/z (I.

(%)): 233[M]+ (100) 235 (11), 218 (48), 205 (100), 127 (48).

78% (37:37 = 7:1) 2--7- , . 70-71/0.2 .. (37) (, ..): 25.38 (3), 122.17 (C3), 124.89 (C6), 126.69 (C4), 124.86 (C5), 127.85 (C8), 135.11 (C7), 135.84 (C4), 148.36 (C8a), 159.99 (C2).

CH Cl N 1H (CDCl3,, ..): 2.63 (3H, CH3), 7.12 (1H, 3H, J 7.6 ), 7.25 (1H, 6H, J 7.6 ), 7.48 (1H, 5H, J 9.2 ), 7.84 (1H, 4H, J 8.4 ), 7.93 (1H, 8H). -, m/z (I. (%)): 177[M]+ (100), 179 (32), 178 (12), 142 (16), 115 (15), 76 (6).

(, ..): 25.38 (3), 122. 2--5- (C3), 124.96 (C6), 126.63 (C8), 126.69 (C4), 130. (37) (C7), 132.85 (C4), 134.88 (C5), 148.14 (C8a), 159. Cl (C2). 1H (CDCl3,, ..): 2.66 (3H, CH3), 7.11 (1H, 3H, J 7.6 ), 7.24 (1H, 6H, CH N J 7.6 ), 7.45 (1H, 7H, J 8.4 ), 7.84 (1H, 4H, J 8 ), 8.20 (1H, 8H, J 7.6 ).

77% (38:38 = 5:1) 3--7--2 , . 95-96oC/0.25 .. (38) (, ..): 12.54 (H2CH3), 19.07 (3), CH 29.35 (CH2CH3), 126.69 (C5), 127.33 (C4), 128. CH (C8), 129.32 (C3), 135.73 (C4), 146.87 (C8a), 164. C Cl N H (C2). 1H (CDCl3,, ..): 1.28-1.39 (3H, CH3), 2.36 c (3, CH3), 2.80-3.00 (2, CH2), 7.39 (1H, 6H, J 7.6 ), 7.57 (1H, 5H, J 7.2 ), 7.77 (1H, 4H), 8.01 (1H, 8H).

-, m/z (I. (%)): 204 [M]+ (100), (69), 207 (21), 177 (29), 154 (7), 140 (21), (23), 99 (7), 84 (28), 75 (14), 63 (24), 51 (11).

13 (, ..): 12.48 (H2CH3), 19. 3--5--2 (3), 29.21(CH2CH3), 125.10 (C7), 125.52 (C5), (38) 126.11 (C8), 127.61 (C4), 130.21 (C3), 132.29 (C4), Cl 147.19 (C8a), 163.89 (C2). 1H (CDCl3, CH3, ..): 1.28-1.39 (3H, CH3), 2.43 c (3, CH3), 2.80-3.00 (2, CH2), 7.10 (1H, 6H, J 7.6 ), CH C N 7.60 (1H, 7H, J 7.2 ), 7.89 (1H, 4H), 8. H (1H, 8H, J 7.6 ).

85% (39:39 = 4:1) 2--7--3 , . 119-120C/0.18 ..

(39) (, ..): 14.05 ((H2)2CH3), H 14.30 (H2CH3), 22.43 (H2H2CH3), 25. C CH (H2CH3), 37.59 (H2H2CH3), 125.48 (C5), (CH2)2CH Cl N 126.63 (C8), 127.34 (C6), 127.86 (C7), 128.09 (C4), 130.25 (C4a), 133.34 (C3), 133.8(C8a), 162.82 (C2).

1H (CDCl3,, ..): 1.00 (3H, CH3, J 7.2 ), 1.18 (3H, CH3, J 7.2 ), 1.77-1.90 (2H, CH2CH2CH3), 2.66 (2, H2CH3, J 7.2 ), 2.88 (2, CH2CH2CH3, J 8 ), 7.21 (1H, 6H, J 7.2 ), 7.34 (1H, 5H, J 7.6 ), 7.52 (1H, 4H), 7.91 c (1H, 8H).

(, ..): 18.05 ((H2)2CH3), 2--5--3 18.44 (H2CH3), 22.36 (H2H2CH3), 26. (39) (H2CH3), 30.01 (H2H2CH3), 36.82 (CH3), Cl H 117.41 (7), 119.58 (4), 120.20 (C6), 127.63 (C8), C CH 127.44 (C5), 129.09 (C4), 130.53 (C3), 145.12 (C8a), 159.56(C2).

(CH2)2CH N 70%. . 94-96C. (, 2--6- ..): 25.30 (3), 122.89 (C3), 135.21 (C6), (40) 128.99 (C4), 126.41 (C5), 122.89 (C8), 130.16 (C7), 135.21 (C4), 145.55 (C8a), 159.01 (C2). 1H (CDCl3,, ..): 2.69 (3H,CH3), 7.28 Cl (1H, 3H, J 7.6 ), 7.60 (1H, 7H, J 7.6 ), CH N 7.73 (1H, 5H), 7.91 (1H, 8H, J 8.4 ) 8.03 (1H, 4H, J 7.6 ). -, m/z (I. (%)):

177[M]+ (100), 179 (47), 142 (48), 116 (27), (24), 51 (23).

82% , 3--6--2 . 114-115o/0.8 .. 13 (, (41) ..): 12.54 (H2CH3), 19.07 (3), 29.35 (CH2), CH Cl 125.30 (C5), 125.39 (C6), 125.87 (C7), 128.95 (C3), CH 128.52 (C8), 132.90 (C4), 134.58 (C4), 146. C N H (C8a), 163.51 (C2). 1H (CDCl3,, ..): 1.25-1.50 (3H, CH3), 2.42 c (3, CH3), 2.70-3.05 (2, CH2CH3), 7.57 (1H, 7H, J ), 7.59 (1H, 4H), 7.76 (1H, 5H), 8.05 (1H, 8H, J 8 ). -, m/z (I. (%)):

203.95 [M]+ (100), 205 (67), 206 (38), 177 (25), 141 (12), 115 (17), 99 (7), 84 (20), 75 (14), 63 (24), 51 (11).

89% , 2--6--3 . 101-102oC/0.2 . . 13 (, (42) ..): 14.11 ((H2)2CH3), 14.38 (H2CH3), 22. H (H2H2CH3), C Cl 25.24 (H2CH3), 37. CH (H2H2CH3), 125.59 (7), 127.83 (5), 129. (CH2)2CH N (8), 129.8(4), 131.19 (6), 132.8(4), 136. (3), 144.78 (8), 162.18 (2). 1H (CDCl3,, ..): 1.02 (3H, CH3, J 7.6 ), 1.25 ), (2H, (3H, CH3, J 7.6 1.80-1. CH2CH2CH3), 2.73 (2, H2CH3, J 7.2 ), 2. (2, CH2CH2CH3, J 8 ), 7.43 (1H, 7H, J 7. ), 7.49 (1H, 5H), 7.59 (1H, 4H), 7.94 (1H, 8H, J 8 ).

94% , 2--6- . 95-96 C/0.4 .. (, (43) ..): 24.85 (CH3), 55.42 (OCH3), 121.71 (C3), MeO 122.01 (C6), 127.32 (C4), 129.89 (C7), 134.78 (C4), 143.67 (C5), 155.49 (C8), 157.45(C2). CH N 1H (CDCl3,, ..): 2.69 (3H, CH3), 3.76 (3H, -OCH3), 6.89 (1H, 3H, J 8 ), 7.48 (1H, 7H, J 7.6 ), 7.63 (1H, 5H), 7.71 (1H, 4H, J 8.4 ), 7.91 (1H, 8H, J 9.2 ). , m/z (I. (%)): 173[M]+ (100), 158 (38), 130 (80), 103 (23), 77 (23).

91% , 3--6--2 . 97-98C/0.3 .. (, (44) ..): 12.86 (H2CH3), 19.02 (3), 30.45 (CH2), CH MeO 55.72 (OCH3), 126.35 (C7), 127.34 (C5), 128. CH (C4), 129.64 (C6), 129.83 (C8), 123.92(C3), 136. C N H (C4), 147.88 (C8a), 163.94 (C2). 1H (CDCl3,, ..): 1.35 (3H, CH3, J 8 ), 2.33 (3H, CH3), 2.87 (2H, CH2, J 8 ), 3.73 (3H, OCH3), 6.80 (1H, 7H, J 8 ), 7.28 (1H, 5H), 7.60 (1H, 4H), 8.00 (1H, 8H, J 8 ).

83% , 6--2--3- . 118C/0.3 .. (, (45) ..): 14.45 ((H2)2CH3), 14.78 (H2CH3), 23. H2 (H2H2CH3), 25.10 (H2CH3), 37. C MeO CH3 (H2H2CH3), 55.39 (OCH3), 104.74 (C5), 113. ), 114.73 (C8), 121.0 (C6), 128.2 (C4a), 129. (CH2)2CH3 (C N (C3), 133.35 (C4), 135.64 (C8a), 157.42 (C2).

1H (CDCl3,, ..): 1.02 (3H, CH3, J 7.2 ), 1.29 (3H, CH3, J 7.6 ), 1.77-1.95 (2H, CH2CH2CH3), 2.73 (2, H2CH3, J 7.6 ), 2.91 (2, CH2CH2CH3, J 8 ), 3.66 (3H, OCH3), 7.04 (1H, 5H, J 7.6 ), 7.22 (1H, 7H, J 7.6 ), 7.74 (1H, 4H), 7.98 (1H, 8H, J 8 ).

88%. T . 64-65/0.2 .. 8--2- (, ..): 24.82 (3), 110.32 (C7), (46) 117.37 (C5), 122.57 (C3), 126.59 (C6), 127. (C4a), 136.04 (C4), 138.65 (C8a), 151.80 (C8), 156.77 (C2). 1H (CDCl3,, ..): 2. CH N OH c (3H, CH3), 7.14 (1H, 7H, J 7.6 ), 7.27 (1H, 5H, J 4.4 ), 7.29 (1H, 3H, J 8.4 ), 7.38 (1H, 6H, J 7.6 ), 8.02 (1H, 4H, J ). -, m/z (I(%)): 159 [M] + (100), 160 (12), 131 (53), 130 (24), 89 (4), 77 (7).

86%. . T . 114 8--3--2 115oC/0.3 .. (, ..):

(47) 11.89 (H2CH3), 18.96 (3), 28.55 (CH2CH3), CH 108.86 (C7), 116.84 (C5), 126.30 (C4), 127.32 (C6), CH 130.54 (C4), 135.61 (C3), 136.50 (C8a), 151.62 (C8), C N H 160.72 (C2). 1H (CDCl3,, ..):

OH 1.00-1.80 (3H, CH3), 2.45 c (3, CH3), 3.20-3. (2, CH2CH3), 7.25-7.45 (1H, 6H), 7.57 (1H, 7H, J 7.6 ), 7.76 (1H, 5H, J 8 ), 7. (1H, 4H). -, m/z (I. (%)):

187.10[M]+ (100), 186 (73), 159 (38), 115 (30), (27), 129 (23), 73 (22).

78%. . T .

8--2--3 105-106oC/0.3 .. 13 (, ..) (48) 14.19 ((H2)2CH3), 14.18 (H2CH3), 21. H (H2H2CH3), C CH 25.03 (H2CH3), 36. (H2H2CH3), 117.09 (C7), 126.60 (C4), 127. (CH2)2CH N (C5), 127.52 (C6), 128.21 (C3), 136.41 (C4), 138. OH (C8a), 151.37 (C8), 159.46 (C2). 1H (CDCl3,, ..): 1.03 (3H, CH3, J 8 ), 1.24 (3H, CH3, J 8 ), 1.80-1.90 (2H, CH2CH2CH3), 2.71 (2, H2CH3, J 7.2 ), 2.92 (2, CH2CH2CH3, J 8 ), 7.13 (1H, 7H, J 7.2 ), 7.26 (1H, 6H, J 7.6 ), 7.44 (1H, 5H, J 7. ), 7.98 (1H, 4H).

92%. (49:49 = 1:1) 13,, 2--6,7 ..: 25.33 (3), 123.04 (C3), 125.53. (C4), (49) 127.95 (C8), 129.78 (C5), 129.99 (C6), 133.70 (C7), Cl 134.89 (C4), 146.39 (C8), 160.50 (C2). 1H, (CDCl3,, ..): 2.75 c (3H, CH3), 7.28 CH Cl N (1H, 3H, J 8.4 ), 7.83 (1H, 8H), 7.91 (1H, 4H, J 8.4 ), 8.11 (1H, 5H). -, m/z (I(%)): 211 [M] + (100), 140 (13), 141 (14), 149 (9), 176 (13), 196 (5), 213(60), 215 (10).

,, ..: 25.07 (3), 123. 2--5,6 (C3), 124.65. (C4), 128.53 (C8), 128.81 (C5).130. (49) Cl (C7), 132.70 (C6), 133.01 (C4), 146.73 (C8), 159. Cl (C2). 1H, (CDCl3,, ..): 2.72 c ( H, CH3), 7.39 (1H, 3H, J 8.4 ), 7.68 (1H, CH N 7H, J 8.4 ), 7.84 (1H, 8H, J 8.4 ), 8,42 (1H, 4H, J 8.4 ). -, m/z (I(%)):

211 [M] + (100), 88 (7), 140 (14), 141 (14), 149 (9), 176 (16), 212 (13), 213(63), 214 (7), 215 (10).

70%. (50:50 = 1.5:1) , 3--6,7--2, ..: 12.36 (H2CH3), 19.11 (3), 29.26 (CH2), (50) 126.38 (C4), 127.18 (C8), 129.45 (C5), 129.85 (C6), CH Cl 130.88 (C3), 134.07 (C7), 134.40 (C4), 146.32 (C8a), CH 164.68 (C2). 1H, (CDCl3,, ..):

C Cl N H 1.39 (3H, CH3, J 7.6 ), 2.55 c (3, CH3), 3.02 (2, CH2, J 7.6 ), 7.73 (1H, 8H), 7.79 (1H, 4H), 8.16 (1H, 5H). -, m/z (I(%)): 239 [M] + (65), 40 (64), 73 (22), 140 (18), 149 (24), 207 (17), 211 (20), 238 (100), 241 (43), 243(7).

,, ..: 12.43 (H2CH3), 19. 3--5,6--2 (3), 29.10 (CH2), 126.15 (C3), 126.25 (C4), (50) 128.41 (C8), 129.65 (C7), 129.91 (C5), 132.57 (C4), Cl 133.46 (C6), 145.60 (C8a), 163.99 (C2). CH Cl 1H, (CDCl3,, ..): 1.38 (3H, CH3, J 7. CH C N ), 2.48 c (3, CH3), 2.98 (2, CH2, J 7.6 ), H 7.64 (1H, 7H, J 8.8 ), 7.91 (1H, 8H, J 8. ), 8.84 (1H, 4H). -, m/z (I(%)):

239 [M] + (47), 240 (100), 43 (17), 55 (18), 57 (18), 69 (17), 207 (20), 238 (73), 241 (31), 243(6).

65%. (51:51 = 2:1) ,, 2--6,7--3 ..: 14.01 (CH23), 14.29 (CH2H2CH3), 22. (51) (CH2H2CH3), (CH23), 25.09 37. H (CH2H2CH3), 126.39 (C4), 127.38 (C8), 129. C Cl CH (C5), 129.70 (C6), 132.28 (C7), 132.34 (C4), 136. (CH2)2CH Cl N (C3), 144.95 (C8a), 163.45 (C2). 1H, (CDCl3,, ..): 1.00-1.10 (3H, CH3), 1.34 (3H, CH3, J 8 ), 1.80-1.90 (2H, CH2CH2CH3), 2.80 (2, H2CH3, J 7.2 ), 2.75-2.95 (2, CH2CH2CH3), 7.70 (1H, 8H), 7.76 (1H, 4H), 8.10 (1H, 5H). -, m/z (I(%)): [M] + (22), 73 (11), 238 (46), 239 (100), 240 (36), 241 (56), 252 (32), 254 (20), 269 (13), 271(3).

,, ..: 14.01 (CH23), 14. 2--5,6--3 (CH2H2CH3), (CH2H2CH3), 22.42 25. (51) (CH23), 37.38 (CH2H2CH3), 126.20 (C4), Cl H 128.45 (C8), 129.65 (C7), 130.02 (C5), 130.44 (C4), C Cl CH 130.58 (C6), 137.33 (C3), 145.19 (C8a), 162.72 (C2).

(CH2)2CH N 1H, (CDCl3,, ..): 0.85-1.00 (3H, CH3), 1.37 (3H, CH3, J 8 ), 1.80-1.90 (2H, CH2CH2CH3), 2.86 (2, H2CH3, J 8 ), 2.75-2.95 (2, CH2CH2CH3), 7.59 (1H, 7H, J 8.8 ), 7.91 (1H, 8H, J 8.8 ), 8.21 (1H, 4H). -, m/z (I(%)): 267 [M] + (31), 211 (13), 238 (60), 239 (100), 240 (46), 241 (67), 252 (37), 254 (19), 269 (20), 271(3).

3.3. N-, N,N 4,4-.

N- (52). 1 FeCl36H2O, 100 , 100 200 . , 140 4 . , , 10%- . , 10% .

. , . 52 33 %, - , .. 195-197 (76-77 (10 ..) {.. 196 [268]}, nD 1.570 (nD20 1.571 [268]).

N,N- (53). 1 FeCl36H2O, 100 , 100 400 . , 140 8 . , , 10%- . , 10% .

. , . 53 92 %, , .. 193-194 (73-74 (10 ..) {.. 194 [268]}, nD 1.555 (nD20 1.557 [268]).

4,4- (54). 1 FeCl36H2O, 100 N,N- 57, 200 . , 140 6 . , , 10%- .

, 10%- . . , . 83%, .. 89-90 {.. 89-91 [269]}. 13,, ..: 38.82 (CH2), 40.97 (3), 113.14 (C3, 5, 3, 5), 129.45 (C2, 6, 2, 6), 130.42 (C1, 1), 149.10 (C4, 4).

1H,, ..: 2.92 c (3H, CH3), 3.86 (2H, H2), 6.84 (4H, 3, 5, 3, 5 H, J 8.4 ), 7.11 (4H, 2, 6, 2, 6 H, J 8.4 ). -, m/z (I., %): [M]+ (100), 253 (68), 210 (30), 134 (24), 126 (17), 118 (16).

3.4. 1,2-, 1,3- Fe- CCl4.

.

1 FeCl3 6H2O, 100 , 200 400 .

, 150 8 . , , .

10%- . .

. .

94%. (6:63 = 2:1). T . 97-99/2 4--2- .. (, ..): 14. (63) (H2CH3), 18.67 (3), 32.22 (CH2), 121.54 (C3), CH3 123.58 (C5), 125.41 (C6), 126.79 (C4), 129. (C8), 129.40 (C7), 144.32 (C4), 147.70 (C8a), 163.68 (C2). 1H (CDCl3,, ..):

CH C N H2 1.41 (3H, CH3, J 6 ), 2.67 c (3, CH3), 2.98 (2, CH2, J 5.2 ), 7.15 (1H, 3H), 7.50 (1H, 6H, J 8 ), 7.68 (1H, 7H, J 8 ), 7.93 (1H, 5H, J 8 ), 8.07 (1H, 8H, J 8 ).

-, m/z (I. (%)): 170.10[M]+ (100), 171 (68), 172 (9), 168 (21), 143 (31), 115 (21), (7).

90%. (16:64 = 2:1). . 85C/0.25 4,8--2 .. 13 (, ..) 13.72 (CH2CH3), (64) 18.92 (CH3), 18.92 (CH3), 32.26 (CH2CH3), CH 122.38 (C3), 122.73 (C5), 125.05 (C6), 128. (C4), 128.27 (C7), 128.52 (C8), 143.99 (C8a), CH N C 144.62 (C4), 164.41 (C2). H H CH (CDCl3,, ..): 1.44 (3H, CH3, J 8 ), 2.20 (3H, CH3), 2.64 (3H, CH3), 2.95-3.04 (2H, CH2CH3), 7.19 (1H, 3H), 7.25-7.45 (1H, 6H), 7.69 (1H, 7H, J 7.2 ), 7.82 (1H, 5H, J 8.8 ). -, m/z (I. (%)):

184.05[M]+ (100), 185 (68), 157 (28), 128 (15), 115 (11), 90 (8) 77 (10), 63 (7), 51 (8).

85% (19:19:65 = 3:1:2). .

4,7--2 75C/0.35 .. (, ..):

(65) 14.07 (CH2CH3), 18.59 (CH3), 21.67 (CH3), 32. (CH2CH3), 120.77 (C3), 126.10 (C4), 126.17 (C5), 126.53 (C6), 127.40 (C8), 139.09 (C7), 147. (C8a), 163.61 (C2). 1H (CDCl3,, CH ..): 1.41 (3H, CH3), 2.54 (3H, CH3), 2.62 (3H, CH3), 2.93-2.98 (2H, CH2), 7.06 (1H, CH H3C N C H2 3H), 7.31 (1H, 6H, J 8 ), 7.45-7.56 (1H, 5H), 7.85 (1H, 8H). -, m/z (I.

(%)): 184.05[M]+ (100), 185 (62), 157 (34), (18), 115 (10), 77 (9), 63 (8).

85% (22:66 = 1.5:1). . 85-86C/0. 4,6--2- .. (, ..): 14. (66) (CH2CH3), 18.77 (CH3), 21.76 (CH3), 31. CH (CH2CH3), 121.52 (C3), 122.67 (C5), 126.72 (C4), H3C 128.48 (C8), 131.44 (C7), 144.37 (C4), 145. CH C N (C8a), 162.53 (C2). 1H (CDCl3,, H ..): 1.20-1.50 (3H, CH3), 2.54 (3H, CH3), 2.65 (3H, CH3), 2.85-3.05 (2, CH2), 7.13 (1H, 3H), 7.74 (1H, 5H), 7.66 (1H, 7H, J 7.6 ), 7.99 (1H, 8H, J 8 ).

79%. (32:67 = 2:1). . 100-102C/0. 4--2,8- .. (, ..): 13. (67) (H2CH3), 15.24 (H2CH3), 18.99 (3), 24. CH (H2CH3), 32.17 (H2CH3), 121.42 (C3), 125. (C5), 126.63 (C7), 127.22 (C4), 127.25 (C6), CH N C 127.33 (C4), 143.16 (C8), 147.33 (C8a), 161. H H2C (C2). 1H (CDCl3,, ..): 1.40-1. CH (3H, CH3), 1.40-1.50 (3H, CH3), 2.70 c (3, CH3), 3.01-3.06 (2, CH2), 3.35-3.50 (2, CH2), 7.17 (1H, 3H), 7.40-7.50 (1H, 6H), 7.52 (1H, 7H, J 8 ), 7.85 (1H, 5H, J ). -, m/z (I. (%)): 198.05[M]+ (100), 199 (64), 182 (16), 171 (28), 157 (6), (7), 115 (10), 77 (10), 63 (7), 51 (5).

87%. (35:68 = 2:1) T . 92-94oC/0.3 4--8--2- . . (, ..): 12. (68) (H2CH3), 18.92 (3), 32.26 (CH2CH3), 121. CH (C3), 123.58 (C5),125.41 (C6), 126.79 (C4), 129.40 (C7), 132.02 (C8), 144.32 (C4), 144. CH C N (C8a), 164.41 (C2). 1H (CDCl3,, H Cl ..): 1.41 (3H, CH3, J 7.6 ), 2.67 c (3, CH3), 2.98 (2, CH2, J 7.6 ), 7.15 (1H, 3H). 7.36 (1H, 6H, J 8 ), 7.50 (1H, 7H, J 7.6 ), 7.83 (1H, 5H, J 8.8 ). -, m/z (I. (%)): 203.95[M]+ (100), 205 (84), (38), 177 (23), 141 (20), 115 (16), 63 (9).

83% (38:38:69 = 3:1:2). . 95 4--7--2 96oC/0.25 .. (, ..):

(69) 13.77 (H2CH3), 18.51 (3), 32.09 (CH2CH3), CH 121.72 (C3), 124.87 (C5),125.21 (C6), 127.65 (C8), 127.88 (C4), 133.74 (C7), 144.19 (C4), 148. CH C Cl N (C8a), 164.80 (C2). 1H (CDCl3,, H ..): 1.28-1.39 (3H, CH3), 2.54 (3, CH3), 2.80-3.05 (2, CH2), 7.03 (1H, 3H). 7.43 (1H, 5H, J 7.6 ), 7.72 (1H, 6H), 7.99 (1H, 8H). -, m/z (I. (%)): [M]+ (100), 205 (72), 207 (19), 177 (22), 154 (9), 115 (23), 84 (13), 75 (18), 63 (19), 51 (9).

80%. (41:70 = 2:1) (, 4--6--2 ..): 13.85 (H2CH3), 18.54 (3), 32.09 (CH2), (70) CH3 122.28 (C3), 122.73 (C5), 125.05 (C6), 128.27 (C7), Cl 129.02 (C8), 133.52 (C4), 144.45 (C4), 144. (C8a), 163.94 (C2). 1H (CDCl3,, CH C N H2 ..): 1.25-1.50 (3H, CH3), 2.57 c (3, CH3), 2.70-3.05 (2, CH2CH3), 7.11 (1H, 3H), 7. (1H, 7H, J 8 ), 7.82 (1H, 5H), 8.07 (1H, 8H, J 8 ). -, m/z (I. (%)):

203.95 [M]+ (100), 205 (56), 206 (29), 177 (30), 141 (13), 115 (14), 77 (14), 63 (24), 51 (9).

75%. (44:71 = 2:1). . 97-98C/0. 4--6--2- .. (, ..): 14. (71) (H2CH3), 20.76 (3), 31.45 (CH2), 55. CH (OCH3), 121.56(C3), 122.34 (C5), 126.35 (C4), MeO 128.23 (C7), 129.64 (C8), 129.83 (C6), 143.43 (C4), CH C N 145.88 (C8a), 162.98 (C2). H H (CDCl3,, ..): 1.20-1.35 (3H, CH3), 2.54 (3H, CH3), 2.85-3.05 (2H, CH2), 3.79 (3H, OCH3), 6.89 (1H, 7H, J 8.4 ), 7.13 (1H, 3H), 7.28 (1H, 5H), 7.99 (1H, 8H, J 8 ).

86% (47:72 = 2:1). . 115-116oC/0. 4--8--2- . . (, ..): 13. (72) (H2CH3), 18.75 (3), 31.29 (CH2CH3), 109. CH (C7), 112.94 (C5), 122.40 (C3), 126.93 (C4), 127.32 (C6), 136.21 (C4), 137.62 (C8a), 152. CH (C8), 164.12 (C2). 1H (CDCl3,, C N H OH ..): 1.00-1.80 (3H, CH3), 2.50 c (3, CH3), 3.90-4.30 (2, CH2CH3), 7.19 (1H, 3H), 7.25-7.45 (1H, 6H), 7.69 (1H, 7H, J 7. ), 7.82 (1H, 5H, J 8 ). -, m/z (I. (%)): 187.10[M]+ (100), 186 (30), 188 (26), 159 (27), 115 (28), 159 (27), 130 (22), 77 (25).

96%. . 42-43C/0.2 ..

(81) (, ..): 120.98 (C3), 126. 4 (C6), 127.79 (C5), 128.93 (C4), 129.02 (C8), 129.39 (C7), 140.01 (C4), 148.20 (C8a), 149. 7 8 N (C2). 1H (CDCl3,, ..): 7.42 (1H, 3H, J 8 ), 7.54 (1H, 6H, J 8 ), 7. (1H, 7H, J 8 ), 7.82 (1H, 5H, J 8.4 ), 8.09 (1H, 4H, J 7.6 ), 8.17 (1H, 8H, J 8. ) 8.93 (1H, 2H, J 8 ). -, m/z (I. (%)): 129.00 [M]+ (100), 130 (11), 118 (28), 102 (22), 76 (7), 51 (10).

92%. . 47-48C/0.3 ..

8- (82) (, ..): 18.11 (CH3), 120. (C3), 125.79 (C6), 126.22 (C5), 128.32 (C4), 129.57 (C7), 137.02 (C8), 136.23 (C4), 147. N CH3 (C8a), 149.22 (C2). 1H (CDCl3,, ..): 2.83 (3H, CH3), 7.39 (1H, 3H, J 8 ), 7.44 (1H, 6H, J 8.4 ), 7.52 (1H, 7H, J ), 7.66 (1H, 5H, J 8 ), 8.12 (1H, 4H, J 8.8 ), 8.95 (1H, 2H, J 8 ). -, m/z (I. (%)): 143.00 [M]+ (100), 144 (11), (43), 115 (14), 89 (6), 51 (4).

71% (83a:83 = 2:1). . 50-51C/0. 7- (83) .. 13 (, ..): 21.77 (CH3), 120.18 (C3), 126.31 (C4), 127.42 (C5), 128. (C8), 128.71 (C6), 135.63 (C4), 139.53 (C7), 148. H3C N (C8a), 150.10 (C2). 1H (CDCl3,, ..): 2.56 (3H, CH3), 7.32 (1H, 3H, J 8 ), 7.41 (1H, 6H, J 6.8 ), 7.68 (1H, 5H, J ), 7.89 (1H, 8H), 8.06 (1H, 4H, J 8 ), 8.88 (1H, 2H, J 8 ). -, m/z (I.

(%)): 143.00 [M]+ (100), 144 (11), 142 (45), (16), 89 (7), 51 (5).

(, ..): 22.34 (CH3), 120. 5- (83) (C3), 126.01 (C6), 127.38 (C8), 128.10 (C4), CH 129.55 (C7), 132.76 (C4), 134.78 (C5), 147. (C8a), 149.78 (C2). 1H (CDCl3,, N ..): 2.68 (3H, CH3), 7.21 (1H, 3H, J 8 ), 7.36 (1H, 6H, J 7.6 ), 7.71 (1H, 7H, J ), 7.92 (1H, 8H), 7.99 (1H, 4H, J 8 ), 8.83 (1H, 2H, J 8 ).

96%. . 73-74C/0.5 ..

6- (84) . H3C (, ..): 21.42 (CH3), 121.01 (C3), 126. (C5), 128.33 (C4), 128.98 (C8), 131.48 (C7), N 135.20 (C4), 136.19 (C6), 147.07 (C8a), 149. (C2). 1H (CDCl3,, ..): 2.52 (3H, CH3), 7.34 (1H, 3H, J 7.6 ), 7.55 (1H, 7H, J 8 ), 7.58 (1H, 5H), 7.97 (1H, 8H, J 8 ), 8.05 (1H, 4H, J 8 ), 8.85 (1H, 2H, J 8 ). -, m/z (I. (%)): 143. [M]+ (100), 144 (11), 142 (48), 115 (14), 89 (6), 71 (4), 51 (3).

88%. . . 269.

8- (85) (, ..): 15.39 (CH3), 24. (CH2), 121.15 (C3), 126.16 (C6), 126.77 (C4a), 128.25 (C5), 128.71 (C7), 136.72 (C8), 143.24 (C4), N C2 H5 147.09 (C8a), 149.59 (C2). H (CDCl3,, ..): 1.40 (2H, CH3, J 8 ), 3.32 (2H, CH2, J 7.6 ), 7.39 (1H, 3H, J 6.8 ), 7.48 (1H, 6H, J 8 ), 7.57 (1H, 5H, J ), 7.66 (1H, 7H, J 8 ), 8.14 (1H, 4H, J 7.6 ), 8.95 (1H, 2H, J 8.8 ).

57%. . 93-94C/0.5 ..

8- (86) . (, ..):

121.78 (C3), 126.35 (C6), 127.09 (C5), 128. (C4), 133.23 (C8), 129.43 (C7), 136.41 (C4), N Cl 144.20 (C8a), 150.79 (C2). H (CDCl3,, ..): 7.44 (1H, 6H, J 8 ), 7.45 (1H, 3H, J 8 ), 7.73 (1H, 5H, J 8 ), 7. (1H, 7H, J 8.4 ), 8.13 (1H, 4H, J 8 ), 9.02 (1H, 2H, J 7.6 ). -, m/z (I. (%)): 163.00 [M]+ (100), 165 (33), 164 (12), 128 (26), 127 (12), 101 (10), 75 (9).

66% (87:87 = 2:1). . 70-71C/0. 7- (87) .. 13 (, ..): 121.65 (C3), 126.64 (C4), 127.34 (C6), 128.13 (C8), 129. (C5), 135.49 (C7), 136.13 (C4), 148.56 (C8a), Cl N 151.08 (C2). 1H (CDCl3,, ..):

7.23-7.30 (1H, 3H), 7.35-7.55 (1H, 6H), 7.69 (1H, 5H, J 8 ), 8.00 (1H, C8H), 8.13 (1H, 4H, J 8 ), 8.99 (1H, 2H, J 8 ).

(, ..): 122.05 (C3), 127. 5- (87) (C4), 126.63 (C8), 127.29 (C6), 129.01 (C7), Cl 135.49 (C5), 136.13 (C4), 149.07 (C8a), 151. (C2). 1H (CDCl3,, ..): 7.23-7. N (1H, 3H), 7.35-7.55 (1H, 6H), 7.76 (1H, 7H, J 8 ), 8.03 (1H, C8H, J 7.6 ), 8.10 (1H, 4H, J 8 ), 9.01 (1H, 2H, J 8 ).

86%. - . .

6- (88) 126-127C/10 .. (, Cl ..): 121.79 (C3), 126.29 (C5), 128.77 (C4), 130.21 (C7), 131.06 (C8), 132.15 (C6), 135.03 (C4), N 146.42 (C8a), 150.53 (C2). H (CDCl3,, ..): 7.40 (1H, 3H, J 7.6 ), 7. (1H, 7H, J 8 ), 7.78 (1H, 5H), 8.03 (1H, 4H, J 8 ), 8.05 (1H, 8H, J 8.4 ), 8.90 (1H, 2H, J 8 ). -, m/z (I. (%)):

163.00 [M]+ (100), 165 (31), 164 (13), 136 (8), 101 (9), 75 (8), 68 (5).

69%. - . .

6- (89) 91-92C/0.4 .. 13 (, ..):

MeO 55.40 (OCH3), 105.09 (C5), 121.26 (C3), 122. (C7), 129.25 (C4), 130.73 (C8), 134.73 (C4), N 144.43 (C8a), 147.83 (C2), 157.63 (C6). 1H (CDCl3,, ..): 3.87 c (3H, OCH3), 6.99 (1H, 5H), 7.29 (1H, 7H, J 7.6 ), 7. (1H, 3H, J 7.6 ), 7.95 (1H, 4H, J 8 ), 7.98 (1H, 8H, J 8.4 ), 8.75 (1H, 2H, J 7. ). -, m/z (I. (%)): 159.00 [M]+ (100), 160 (12), 144 (11), 129 (14), 116 (67), (17), 63 (9).

79%. .

8- (90) . 72-76C. 13 (, ..): 110. (C7), 118.03 (C5), 121.59 (C3), 127.65 (C6), 128. (C4), 136.18 (C4), 138.29 (C8a), 148.09 (C2), N OH 152.51 (C8). 1H (CDCl3,, ..):

7.19 (1H, 7H, J 8 ), 7.33 (1H, 5H, J 8. ), 7.43 (1H, 3H, J 8 ), 7.46 (1H, 6H, J 7.2 ), 8.15 (1H, 4H, J 8 ), 8.30 . (1H, OH), 8.79 (1H, 2H, J 7.6 ). -, m/z (I. (%)): 145.00 [M]+ (100), 146 (10), (51), 90 (18), 89 (17), 63 (11), 59 (9).

95% (5:91 = 1:2). T . 80-81/2 4- (91) .. (, ..): 18.40 (3), CH 121.87 (C3), 123.85 (C5), 126.33 (C6), 127. (C4), 128.95 (C7), 129.76 (C8), 144.50 (C4), N 147.76 (C8a), 150.01 (C2). H (CDCl3,, ..): 2.68 c (3H, CH3), 7.18 (1H, 3H, J 8 ), 7.53 (1H, 6H, J 7.6 ), 7.68 (1H, 7H, J 7.6 ), 7.95 (1H, 5H, J 9.2 ), 8.09 (1H, 8H, J 8.4 ), 8.73 (1H, 2H, J 8. ). -, m/z (I. (%)): 143.18[M]+ (100), 128 (34), 115 (19), 101 (8), 89 (5), 75 (4), 51(4).

80% (15:92 = 1:2). T . 65-66/0.3 4,8- (92) CH3 .. (, ..): 18.91 (3), 18.94 (3), 121.79 (C3), 125.55 (C6), 126. (C5), 129.42 (C7), 136.26 (C8), 139.45 (C4), N 148.84 (C4), 147.00 (C8a), 148.94 (C2). CH 1H (CDCl3,, ..) 2.79 (3H, CH3), 2.89 (3H, CH3), 7.15-7.30 (1H, 3H), 7.47 (1H, 6H, J 7.2 ), 7.50-7.65 (1H, C7) 7.86 (1H, 5H, J 8.4 ), 8.84 (1H, 2H, J 7.6 ). , m/z (I. (%)): 157.00[M]+ (100), (31), 143 (10), 115 (8), 71 (4), 65 (2), 52 (2).

78% (18:18:93 = 2:1:3). 4,7- (93) . (, ..): 18. CH 21.72 (3), 121.13 (C3), 123.56 (C6), (3), 126.34 (C5), 128.56 (C4), 128.82 (C8), 139.3 (C7), H3C N 144.15 (C4), 148.10 (C8a), 150.04 (C2). 1H (CDCl3,, ..) 2.54 (3H, CH3), 2.64 (3H, CH3), 7.14 (1H, 3H, J 7.2 ), 7.38 (1H, C8H, J 6.8 ), 7.85-7.95 (1H, 5,6H), 8.71 (1H, 2H, J 8 ).

93% (21:94 = 1:1). 4,6- (94) . (, ..): 18. CH (3), 21.80 (CH3), 121.81 (C3), 122.75 (C5), H3C 128.20 (C4), 129.60 (C8), 131.34 (C7), 136. N (C4), 143.53 (C6), 146.46 (C8a), 149.21 (C2).

1H (CDCl3,, ..): 2.59 c (3H, CH3), 2.69 (3H, CH3), 7.16 (1H, 3H, J 8 ), 7.52 (1H, 7H, J 8.4 ), 7.72 c (1H, 5H), 7. (1H, 8H, J 8.4 ), 8.69 (1H, 2H, J 7.6 ).

-, m/z (I. (%)): 158.00[M]+ (100).

87% (31:95 = 1:2). 4--8- . 73-74C/0.2 .. (95) (, ..): 15.22 (H2CH3), 25. CH (H2CH3), 18.97 (CH3), 121.79 (C3), 125.39 (C5), 126.03 (C6), 126.43 (C4), 127.67 (C7), 136. N (C8), 143.40 (C4), 144.36 (C8a), 148.91 (C2).

C2H 1H (CDCl3,, ..): 1.30-1.60 (3H, CH3), 2.68 c (3, CH3), 3.30-3.50 (2, CH2), 7.51 (1H, 6H, J 7.6 ), 7.60 (1H, 7H, J 7.6 ), 7.86 (1H, 5H, J 8.4 ), 7.99 4H). -, (1H, m/z (I. (%)):

170.10[M]+ (100), 171 (83), 143 (63), 128 (16), 115 (36), 63 (40), 51 (50).

94% (34:96 = 1:3). . 87-89oC/0.2 4--8- . . (, ..): 18.98 (3), (96) 121.68 (C3), 125.41 (C6), 126.41 (C4), 127. CH (C7), 127.65 (C5), 142.30 (C8), 143.28 (C4), 144. (C8a), 148.84 (C2). 1H (CDCl3,, N ..): 2.68 (3H, CH3), 7.20-7.40 (1H, 3H), Cl 7.45-7.60 (1H, 6H), 7.58 (1H, 7H, J 7. ), 7.84 (1H, 5H, J 8.4 ), 8.80 (1H, 2H).

-, m/z (I. (%)): 177. 1[M]+, (14), 115 (15), 76 (7).

79% (37:37:97 = 2:1:3). . 92 4--7- 93oC/0.3 . . (, ..):

(97) 18.55 (3), 122.04 (C3), 125.23 (C6), 127. (C4), 130.25 (C5), 127.16 (C8), 134.90 (C7), 144.40 (C4), 150.19 (C8a), 151.14 (C2). CH 1H (CDCl3,, ..): 2.75 (3H, CH3), 7.10 7.20 (1H, 3H), 7.30-7.55 (1H, 6H), 7.70 Cl N 8.00 (1H, 5H), 8.07 (1H, 8H), 8.60-8.78 (1H, 2H). -, m/z (I. (%)): 177[M]+ (100), 179 (34), 178 (10), 143 (12), 115 (19), (9).

82% (40:98 = 1:2). . 100-101C/0. 4--6- .. 13 (, ..): 18.57 (3), (98) 122.85 (C3), 135.10 (C6), 127.05 (C4), 126. CH (C5), 122.85 (C8), 130.26 (C7), 143.93 (C4), 145. Cl (C8a), 150.07 (C2). 1H (CDCl3,, N ..): 2.69 (3H,CH3), 7.25 (1H, 3H, J 7. ), 7.72 (1H, 7H, J 7.6 ), 7.72 (1H, 5H), 8.10 (1H, 8H, J 8.4 ), 8.76 (1H, 2H, J ). -, m/z (I. (%)): 177[M]+ (100), 179 (42), 142 (51), 116 (27), 99 (14), 51 (27).

89% (43:99 = 1:1). . 4--6 . 26-29C.. (, ..): 18. (99) (3), 55.53 (OCH3), 101.9 (C5), 121.47 (C7), CH 122.15 (C3), 129.25 (C4), 131.46 (C4), 142. MeO (C8), 144.01 (C8a), 147.67 (C2), 157.60 (C6).

N H (CDCl3,, ..): 2.63 (3H,CH3), 3.94 c (3H, OCH3), 7.15-7.18 (2H, 3,5H), 7.35 (1H, 7H, J 7.6 ), 8.00 (1H, 8H, J 8.4 ), 8.61 (1H, 2H, J 8.8 ).

90% (46:100 = 1:1). T . 65-66/0. 8--4 .. 13 (, ..): 18.72 (3), (100) 109.68 (C7), 114.87 (C5), 122.46 (C3), 127.2 (C4a), CH 128.41 (C6), 138.04 (C4), 145.00 (C8a), 147. (C8), 152.57 (C2). 1H (CDCl3,, N ..): 2.68 c (3H, CH3), 7.12-7.28 (2H, 3,5H), OH 7.43-7.45 (2H, 6,7H), 8.61 (1H, 2H, J 8. ). -, m/z (I(%)): 159 [M] + (100), 160 (12), 131 (77).

3.5. N- 0.5 FeCl36H2O, 100 , 200 30 .

, 160-180 6-12 . , , . , 10%- . .

, .

85%. N- (113) . . 73-74/0.4 .. ( 3' 3 2' 86oC/1 .. [225]). (, 4 N 4' ..): 152.22 (C1), 129.04 (C3,5), 119.36 (C4), 5 6' 5' 116.66 (C2,6), 50.81 (C2',6'), 25.88 (C3',5'), 24. (C4'). 1H (CDCl3,, ..): 7.25-7. (2H, 3,5H), 7.00 (2H, C2,6H, J 8 ), 6.80 6.96 (1H, 4H), 3.15-3.26 (4H, C2',6'H), 1.70 1.80 (4, C3',5'H), 1.55-1.68 (2, C4'H).

42%. . N-(2-) . 96-97/2 .. (, (114) ..): 149.87 (C1), 131.56 (C3), 126.74 (C5), CH 132.41 (C2), 124.31 (C4), 119.32 (C6), 54. N (C2',6'), 25.74 (C3',5'), 23.76 (C4'), 18.31 (CH3).

1H (CDCl3,, ..): 6.80-6.92 (1H, C5H), 7.08-7.20 (1H, C3H), 7.09-7.28 (1H, C4H), 6.91-7.05 (1H, 6H), 2.41 (3, CH3), 2.99 (4H, C2',6'H), 1.86 . (4, C3',5'H), 1.50-1.70 (2, C4'H). -, m/z (I. (%)): 175 [M]+ (86), 176 (11), 174 (100), (28), 134 (12), 132 (18), 130 (7), 120 (15), (21), 118 (86), 117 (12), 91 (38), 77 (8), 65 (22), 55 (6).

47%. . N-(3-) . 95-97/0.5 .. (, (115) ..): 148.34 (C1), 139.45 (C3), 129.32 (C5), H3C 124.56 (C4), 119.90 (C2), 115.62 (6), 53. N (C2',6'), 24.69 (C3',5'), 23.18 (C4'), 21.64 (CH3).

1H (CDCl3,, ..): 7.05-7.30 (1H, 5H), 6.80-6.90 (1H, C6H), 6.53 c (1H, C2H), 6.45-6.70 (1H, 4H), 3.23-3.26 (4H, C2',6'H), 2.33 (3, CH3), 2.14-2.25 (4, C3',5'H), 1.48-1.73 (2, C4'H). -, m/z (I. (%)): 175 [M]+ (81), 174 (100), 160 (7), (12), 134 (15), 120 (9), 119 (36), 118 (28), (38), 65 (16).

61%. . N-(4-) . 106-107/1 .. 13 (, (116) ..): 142.18 (C1), 137.94 (C4), 129.92 (C3,5), 120.42 (C2,6), 56.15 (C2',6'), 23.17 (C3',5'), 21. H3C N (C4'), 20.86 (CH3). 1H (CDCl3,, ..): 7.56 (1H, 3,5H, J 8 ), 7.11 (1H, 2,6H, J 8 ), 3.30-3.45 (4H, C2',6'H), 2.24 (3, CH3), 1.70-2.15 (4, C3',5'H), 1.52-2.05 (2, C4'H). -, m/z (I. (%)): [M]+ (98), 174 (100), 160 (12), 146 (9), 134 (13), 120 (9), 119 (32), 118 (24), 91 (29), 64 (10).

38%. . N-(2-) . 75-77/0.3 .. (, (117) ..): 152.29 (C1), 139.26 (2), 128.87 (C3), C 2 H 126.36 (C5), 123.62 (C4), 119.85 (C6), 54. N (C2',6'), 26.60 (C3',5'), 24.36 (CH3), 23.44 (C4'), 14.89 (C8). 1H (CDCl3,, ..): 7. (1H, 5H), 7.19 (1H, 3H), 7.10 (1H, 4H), 6.81 (1H, C6H), 3.51-3.69 (2, CH2, J 7. ), 2.69-3.02 (4H, C2',6'H), 1.69-1.93 (4, C3',5'H), 1.51-1.69 (2, C4'H), 1.30 (3, CH3, J 7.6 ).

33%. . N-(2-) . 89-90/0.2 .. (, (118) ..): 148.74 (C1), 130.49 (C3), 128.87 (C4), Cl 127.48 (C5), 123.22 (C2), 120.55 (6), 52. N (C2',6'), 26.25 (C3',5'), 24.26 (C4'). 1H (CDCl3,, ..): 7.33 (1H, 3H), 7.15-7.22 (1H, 5H), 7.04 (1H, C6H, J 8 ), 6.92 (1H, 4H), 2.75-3.18 (4H, C2',6'H), 1.65-1.88 (4, C3',5'H), 1.45-1.88 (2, C4'H).

35%. . N-(3-) . 115-116/0.08 .. (119) (, ..): 152.80 (C1), 134.85 (C3), 130.26 (C5), Cl 118.95 (C4), 116.16 (C6), 114.49 (C2), 50. N (C2',6'), 25.52 (C3',5'), 24.14 (C4'). 1H (CDCl3,, ..): 7.15 (1H, C5H, J 8 ), 6.84 (1H, C4H, J 8 ), 6.92 (1H, C2H), 6.79 (1H, 6H, J 8 ), 3.10-3.22 (4H, C2',6'H), 1.53-1. (4, C3',5'H), 1.53-1.63 (2, C4'H).

40%. . N-(4-) . 92-94/0.5 .. (, (120) ..): 144.90 (C1), 128.95 (C3,5), 123.07 (C4), 118.11 (C2,6), 51.19 (C2',6'), 25.46 (C3',5'), 23. Cl N (C4'). 1H (CDCl3,, ..): 6.93 (2H, 3,5H, J 8 ), 6.60 (2H, C2,6H, J 8 ), 3.07-3.20 (4H, C2',6'H), 1.69-1.83 (4, C3',5'H), 1.52-1.66 (2, C4'H).

35%. . N-(4-) . 100-101/2 .. 13 (, (121) ..): 143.02 (C1), 160.09 (C4, JF 244 ), 116.28 (C3,5, JF 22 ), 121.47 (C2,6), 55. F N (C2',6'), 24.20 (C3',5'), 22.35 (C4'). 19F (CDCl3,, ..): 116.13. H (CDCl3,, ..): 7.46 (2H, 3,5H), 6.59 (2H, 2,6H), 3.22 (4H, C2',6'H), 1.93 (4, C3',5'H), 1.59 (2, C4'H).

88%. . N- . 89-90/1 .. (.. 81/0.5 (122) .. [225]). (, ..): 148. 2' 3 3' (C1), 129.22 (C3,5), 115.53 (C4), 111.81 (C2,6), N 47.72 (C2',5'), 25.56 (C3',4'). 4' H 5 5' (CDCl3,, ..): 7.30-7.38 (2H, 3,5H), 6.74 6.82 (1H, 4H), 6.69 (2H, C2,6H, J 8 ), 3.30-3.40 (4H, C2',5'H), 2.05-2.15 (4, C3',4'H).

-, m/z (I. (%)): 147 [M]+ (94), (10), 146 (100), 119 (9), 118 (7), 104 (25), 92 (6), 91 (72), 77 (46), 65 (7), 51 (19) 50%. . N-(2-) . 122-124/10 .. 13 (, (123) ..): 148.14 (C1), 131.92 (C3), 129.20 (C5), CH 126.56 (C2), 121.68 (C4), 116.59 (C6), 49. N (C2',5'), 24.52 (C3',4'), 20.35 (H3). 1H (CDCl3,, ..): 7.12-7.30 (1H, C5H), 6.98 7.12 (1H, C3H), 6.88-6.98 (1H, C4H), 6.60 6.80 (1H, 6H), 3.25-3.45 (4H, C2',5'H), 2.43 (3H, H3), 1.96-2.15 (4, C3',4'H).

63%. . N-(3-) . 93-95 /0.08 .. 13 (, (124) ..): 148.15 (C1), 138.83 (C3), 129.11 (C5), H3C 116.61 (C4), 112.53 (C2), 109.14 (C6), 47. N (C2',5'), 25.55 (C3',4'), 21.98 (H3). 1H (CDCl3,, ..): 7.20-7.35 (1H, C5H), 6.63 (1H, C6H, J 8 ), 6.53 (H, 2H), 6.52 (1H, C4H, J 8 ), 3.37-3.40 (4H, C2',5'H), 2.45 (3H, H3), 2.08-2.11 (4, C3',4'H). , m/z (I. (%)): 161 [M]+ (72), 160 (100), 118 (22), 117 (9), 105 (69), 91 (56), 89 (11), (14), 65 (34), 63 (10), 51 (11).

75%. . N-(4-) . 108-110/0.1 .. (125) (, ..): 145.85 (C1), 129.68 (C3,5), 124.98 (C4), 112.19 (C2,6), 48.26 (C2',5'), 25.39 (C3',4'), 20. H3C N (H3). 1H (CDCl3,, ..): 7.07 (2H, 3,5H, J 8 ), 6.56 (2H, C2,6H, J 8 ), 3.20-3.40 (4H, C2',5'H), 2.28 (3H, H3), 2.01 (4, C3',4'H). -, m/z (I. (%)): [M]+ (76), 160 (100), 118 (31), 117 (12), 105 (79), 91 (64), 89 (16), 78 (9), 77 (18), 65 (38), 63 (10), 51 (13).

47%. . N-(2-) . 88-90/0.8 .. (, (126) ..): 148.40 (C1), 135.60 (C2), 129.46 (C3), CH2CH 126.27 (C5), 121.42 (C4), 116.88 (C6), 52. N (C2',5'), 25.31 (C3',4'), 24.91 (CH2), 14.49 (CH3).

1H (CDCl3,, ..): 7.22 (1H, C3H, J 7.2 ), 7.14 (1H, 6H, J 8 ), 6.94 7.01 (1H, C4H), 6.63-6.77 (1H, C5H), 3.12 3.40 (4H, C2',5'H), 2.68-2.85 (2, C7H), 1.90-2.12 (4, C3',4'H), 1.29 (3, C8H, J 7.6 ). -, m/z (I. (%)): 175 [M]+ (80), 174 (100), 160 (7), 146 (12), 134 (15), (9), 119 (35), 118 (27), 91 (37), 65 (16).

51%. . N-(2-) . 115-117 /0.6 .. (127) (, ..): 146.98 (C1), 131.29 (C3), 127.29 (C5), Cl 126.44 (C2), 123.59 (C4), 120.91 (C6), 51. N (C2',5'), 25.20 (C3',4'). 1H (CDCl3,, ..): 7.28-7.40 (1H, C3H), 7.11-7.22 (1H, C5H), 6.92-7.08 (1H, 6H), 6.75-6.90 (1H, C4H), 3.32-3.51 (4H, C2',5'H), 1.88-2.08 (4, C3',4'H). -, m/z (I. (%)): 181. [M]+ (100), 182 (29), 180 (95), 140 (24), 138 (42), 124 (85), 118 (17), 117 (37), 111 (45), 90 (29), (31), 77 (36), 74 (25), 73 (20), 62 (16), 50 (30).

50%. . N-(3-) . 120-122/0.4 .. (128) (, ..): 148.83 (C1), 134.78 (C3), 129.98 (C5), Cl 114.95 (C4), 111.27 (C2), 109.89 (C6), 47. N (C2',5'), 25.41 (C3',4'). 1H (CDCl3,, ..): 7.04-7.08 (1H, C5H), 6.55 (1H, C4H, J ), 6.46 (1H, C2H), 6.37 (1H, 6H, J 8 ), 3.05-3.32 (4H, C2',5'H), 1.85-2.05 (4, C3',4'H).

60%. . N-(4-) . 132-134/0.3 .. (129) (, ..): 146.51 (C1), 128.90 (C3,5), 120.04 (C4), 112.73 (C2,6), 47.78 (C2',5'), 25.56 (C3',4'). Cl N 1H (CDCl3,, ..): 7.14 (2H, 3,5H, J ), 6.46 (2H, C2,6H, J 8 ), 3.17-3.31 (4H, C2',5'H2), 1.96-2.09 (4, C3',4'H). -, m/z (I. (%)): 181.5 [M]+ (88), 183 (23), (30), 180 (100), 138 (37), 127 (17), 125 (66), (19), 110 (46), 91 (16), 89 (19), 75 (20), 63 (18), 52 (19), 51 (18).

45%. . N-(4-) . 92-94 /1 .. (, (130) ..): 144.83 (C1), 154.83 (C4, JF 232 ), 112.14 (C3,5, JF 8 ), 115.43 (C2,6, JF F N ), 48.18 (C2',5'), 25.53 (C3',4'). F (CDCl3,, ..):

-130.73. H (CDCl3,, ..): 6.91-7.00 (2H, 3,5H), 6.44 6.53 (2H, 2,6H), 3.18-3.32 (4H, C2',5'H), 1.92 2.10 (4, C3',4'H). -, m/z (I. (%)):

165 [M]+ (94), 164 (73), 136 (11), 124 (15), (19), 122 (63), 111 (12), 110 (21), 109 (100), (10), 94 (46), 75 (14), 64 (9). 50 (10).

42%. . N-(3-) . 110-112 /0.02 .. 13 (131) (, ..): 156.84 (C3), 149.52 (C1), 130.02 (C5), HO 104.61 (C6), 102.77 (C4), 98.90 (C2), 47.70 (C2',5'), N 25.40 (C3',4'). 1H (CDCl3,, ..):

7.03-7.14 (1H, C5H), 6.18 (1H, C2H), 6.12 6.32 (1H, C4H), 6.03-6.12 (1H, 6H), 3.23 3.27 (4H, C2',5'H), 1.92-2.01 (4, C3',4'H), 7. (H). -, m/z (I. (%)): 163 [M]+ (93), 164 (12), 162 (100), 135 (9), 134 (17), (17), 108 (9), 107 (55), 93 (21), 77 (10), 65 (30), 63 (8), 53 (8), 51 (7).

3.6. N- .

1 FeCl36H2O, 100 , 200 CCl 80-85 8 . , 10%- Na2CO3 0.5-1 , , . , N- 136, 142-144 .

96%. , .

N- 124-125oC/2 .., (200-202oC/30 . ..

(136) [241]). , (, ..): 65. H2 H C C (PhH2N), 126.79, 127.98, 128.28, 128.49, N 128.60, 130.76, 136.17, 139.29, 162. (N=CHPh). 1H (CDCl3), (, ..):

4.86 c (2H, PhH2N), 6.86-8.20 (10H, Ar), 8. c (1H, N=CHPh). -, m/z (I., %):

195.25 [M]+ (35), 194 (33), 165 (5), 152 (3), (15), 91 (100), 65 (20), 51 (5).

72%. , (, ..): 62. N-(2-)-(2 (PhH2N), 126.69 (C3), 126.98 (C2), 128.44 (C5), )- (142) 128.51 (C4), 129.37 (C2), 129.68 (C3), 129. H2 H 2' (C5), 131.75 (C4), 133.46 (C6), 135.33 (C6), C C N 3' 1 1' (C1), (C1), 135.53 136.88 159. 4 4' 6' 6 Cl Cl (N=CHPh). 1H (CDCl3), (, ..):

5' 4.99 c (2H, PhH2N), 7.20-7.5 (8H, Ar), 8.92 c (1H, N=CHPh. -, m/z (I. (%)): [M]+ (100), 265 (18), 266 (60).

78%. , (, ..): 64. N-(3-)-(3 (PhH2N), 126.06 (C2), 126.69 (C4), 127. )- (143) (C6,6), 127.93 (C2), 128.03 (C3), 129.80 (C4), H2 H 129.92 (C3), 134.39 (C5,5), 137.70 (C1), 141. C C N (C1), 160.94 (N=CHPh). 1H (CDCl3), (, ..): 4.79 c (2H, PhH2N), 7.10-7.82 (8H, Cl Cl Ar), 8.34 c (1H, N=CHPh). -, m/z (I. (%)): 264 [M]+ (100), 265 (20), 266 (59).

85%. . 123-124oC/0.3 . .

N- , (, ..): 58.08 (-H2N), 124.88 (C4), 125.34 (C5), 126.93 (C3), 127. (144) (C4), 129.39 (C5), 131.03 (C3), 141.35 (C2), 141.59 (C2), 155.47 (N=CH-). 1H 4' 3' 5' 2 2' (CDCl3), (, ..): 4.97 c (2H, -H2N), 7.01-7. N S C C S H H2 (1H, C3H), 7.10 (1H, C4H, J 7.2 ), 7.24 7.28 (2H, C5,4H), 7.35 (1H, C3H, J 8 ), 7.43 (1H, C5H, J 8 ) 8.44 c (1H, N=CH-).

. , ( ) (). , CCl4, CHCl3 ( ).

() . .

3.7. 2--3-.

1 FeCl36H2O, 100 , 30 , 100 200 . , 140 8 . , , . 10%- . . . 147-149 .

90%. . 143-144/0.2 . . ( 2- (147) . 80-82 [270]). (, ..):

4a 119.52(C3), 127.15(C6), 127.21 (C4), 127.67 (C5), 6 2' 127.80 (C7), 131.83 (C8), 139.01 (C4), 145. 1' 7 3' 8a N (C8a), 157.89 (C2) 128.21 (3,5), 129.07 (2,6), 4' 6' 5' 130.40 (4), 137.16 (C1). H (CDCl3,, ..): 7.76 (1H, 3H, J 8 ), 7.83 (1H, 5H, J 8 ),7.85 (1H, 7H, J 8 ), 7.40 7.60 (1H, 6H), 8.33 (1H, 8H, J 8.8 ), 8.50 (1H, 4H, J 8.4 ), 8.18 (1H, 2H, J 7. ), 8.18 (1H, 6H, J 7.6 ), 7.40-7.60 (3H, 2,4,5H). -, m/z (I. (%)):


205.00[M]+ (100), 102 (10), 176 (5), 76 (4), (2).

84%. . 137-138/0.2 . .

2--3- (, ..): 20.53 (CH3), 126. (148) (C3), 126.50 (C6), 127.45 (C5), 127.96 (C7), 128. CH (C4), 129.19 (C8), 136.61 (C4), 146.40 (C8a), 160.30 (C2) 128.65 (3,5), 128.79 (2,6), 129. N (4), 140.73 (C1). 1H (CDCl3,, ..): 2.41 (3H, CH3), 7.38-7.48 (5H, 5, 7, 3,4, H), 7.55-7.58 (1H, 6H), 7.60-7.64 (1H, 8H), 7.93 (1H, 4H), 8.13 (2H, 2,6H, J ). -, m/z (I. (%)): 218.05[M]+ (100), 209 (5), 75 (4), 63 (4), 40 (3).

78%. . 150-152/0.2 . .

2--3- (, ..): 14.75 (CH3), 26. (149) (CH2), 126.20 (C3), 127.15 (C6), 127.67 (C5), H 127.80 (C7), 129.72 (C4), 131.83 (C8), 134. C CH (C4), 146.38 (C8a), 160.66 (C2) 128.32 (3,5), N 128.76 (2,6), 129.27 (4), 140.94 (C1). 1H (CDCl3,, ..): 1.22 (3H, CH3, J ), 2.66 (2H, CH2, J 8 ), 7.35-7.65 (5H, 5, 7, 3,4,5H), 7.62-7.68 (1H, 6H), 7.75-7.80 (1H, 8H), 8.06 (1H, 4H), 8.17 (2H, 2,6H, J 7.6 ). -, m/z (I. (%)): 232.00[M]+ (100), 217 (35), 109 (21), 77 (8), 63 (6), 52 (2).

1. , , 1,2- 1,3- Cl4 Fe- , FeCl3.6H2O. , 1,2- 1,3-, 96%.

2. N-, N,N- 4,4 CCl4 FeCl3.6H2O.

3. 1,4-- 1,5- Fe- N N- 20-88% 4. N- CCl4 FeCl3.6H2O. : 2-- 3-, 2-.

5. 2- , FeCl3.6H2O CCl4.

1. Craig J.C., Person P.E. Potential antimalarials. Tribromomethylquinolines and positive halogen compounds // J. Med. Chem. - 1971. - V. 14. - P. 1221-1222.

2. Dillard R.D., Pravey D.E., Benslay D.N. Synthesis and anti-inflammatory activity of some 2,2-dimethyl-1,2-dihydroquinolines // J. Med. Chem. 1973. V.

16. P. 251-253.

3. Johnson J.V., Rauckman B.S., Baccanari D.P., Roth B. 2,4-Diamino-5 benzylpyrimidines and analogs as antibacterial agents. 1,2-Dihydroquinolylmethyl analogs with high activity and specificity for bacterial dihydrofolate reductase // J.

Med. Chem. 1989. V. 32. P. 1942-1949.

4. Stille J.K. Polyquinolines // Macromolecules. 1981. V. 14. P. 870-880.

5. Agarwal A.K., Jenekhe S.A. New conjugated polyanthrazolines containing thiophene moieties in the main chain // Macromolecules. 1991. V. 24. P.

6806-6808.

6. Agarwal A.K., Jenekhe S.A. Electrochemical properties and electronic structures of conjugated polyquinolines and polyanthrazolines // Chem. Mater. 1996. V. 8. P. 579-589.

7. Zhang X., Shetty A.S., Jenekhe S.A. Electroluminescence and photophysical properties of polyquinolines // Macromolecules. 1999. V. 32. P. 7422-7429.

8. Zhang X., Shetty A.S., Jenekhe S.A. Electroluminescence of multicomponent conjugated polymers. Roles of polymer/polymer interfaces in emission enhancement and voltage-tunable multicolor emission in semiconducting polymer/polymer heterojunctions // Macromolecules. 2000. V. 33. P. 2069 2082.

9. Jenekhe S.A., Lu L., Alam M.M. New conjugated polymers with donor acceptor architectures: synthesis and photophysics of carbazole-quinoline and phenothiazine-quinoline copolymers and oligomers rxhibiting large intramolecular charge transfer // Macromolecules. 2001. V. 34. P. 7315-7324.

10. Skraup Z.H. Eine synthese des chinolins // Chem. Ber. 1880. V. 13. P.

2086.

11. Doebner O., Miller W.V. Ueber Chinaldinbasen // Chem. Ber. 1883. V.

16. P. 2464-2472.

12. Theoclitou M.-E., Robinson L.A. Novel facile synthesis of 2,4-substituted 1,2-dihydroquinolines via a modied Skraup reaction // Tetrahedron Lett. 2002.

V. 43. P. 3907-3910.

13. Marco-Contelles J., Prez-Mayoral E., Samadi A., Carreiras M.C., Soriano E. Recent Advances in the Friedlander Reaction // Chem. Rev. 2009. V. 109. P. 2652-2671.

14. .., .. - // . . - 2006. - V. 6. - P. 803-824.

15. Kouznetsov V.V., Mndez L.Y.V., Gmez C.M.M. Recent Progress in the Synthesis of Quinolines // Curr. Org. Chem. 2005. V. 9. P. 141-161.

16. Cohn E.W. A modification of the Skraup synthesis of quinoline // J. Am.

Chem. Soc. 1930. V. 52. P. 3685-3688.

17. Manske R.H.F., Kukla M. Skraup synthesis of quinolines // Org. React. 1953. V. 7. P. 59-98.

18. Linderman R.J., Kirollos S.K. Regioselective synthesis of trifluoromethyl substituted quinolines from trifluoroacetyl acetylenes // Tetrahedron Lett. 1990. V. 31. Issue 19. P. 2689-2692.

19. Cho C.S., Oh B.H., Kim T.J., Shim S.C. Synthesis of quinolines via ruthenium-catalysed amine exchange reaction between anilines and trialkylamines // Chem. Commun. 2000. P. 1885-1886.

20. Crouse B., Begue J.P., Daniele B.D. Synthesis of 2-CF3-tetrahydroquinoline and quinoline derivatives from CF3-N-arylaldimine // J. Org. Chem. 2000. V.

65. P. 5009-5013.

21. Bergstrom F.W. Heterocyclic nitrogen compounds. Part IIA. Hexacyclic compounds: pyridine, quinoline and isoquinoline. // Chem. Rev. 1944. V. 35. P. 77-277.

22. Litvinov V.P. Advances in the chemistry of naphthyridines // Adv.

Heterocycl. Chem. 2006. V. 91. P. 189-300.

23. Monrad R.N., Madsen R. Ruthenium-catalysed synthesis of 2- and 3 substituted quinolines from anilines and 1,3-diols // Org. Biomol. Chem. 2011. V. 9. P. 610-615.

24. Huma H.Z.S., Iqbal J., Rajkumar H. Cu(I)-catalyzed three component coupling protocol for the synthesis of quinoline derivatives // Tetrahedron Lett. 2002. V. 43. P. 6485-6488.

25. Jiang B., Yui-Gui S.J. Zn(II)-mediated alkynylation-cyclization of o trifluoroacetyl anilines: one-pot synthesis of 4-trifluoromethyl-substituted quinoline derivatives // J. Org. Chem. 2002. V. 67. P. 9449-9451.

26. Roberts L., Egan T.J., Joiner K.A., Hoppe H.C. Differential effects of quinoline antimalarials on endocytosis in Plasmodium falciparum // Antimicrob.

Agent. Chem. 2008. P. 1840-1842.

27. Roma G., Di Braccio M., Grossi G., Mattioli F., Ghia M. 1,8 Naphthyridines. 9-Substituted N,N-dialkyl-5-(alkylamino or cycloalkylamino) [1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides, new compounds with anti-aggressive and potent anti-inammatory activities // Eur. J. Med. Chem. 2000. V. 35. P. 1021-1035.

28. Dube D., Blouin M., Brideau C., Chan C.C., Desmarais S., Ethier D., Falgueyret J.P., Friesen R.W., Girard M., Girard Y., Guay J., Riendeau D., Tagari P., Young R.N. Quinolines as potent 5-lipoxygenase inhibitors: synthesis and biological profile of L-746,530 // Bioorg. Med. Chem. Lett. 1998. V. 8. P.

1255-1260.

29. Chen Y.L., Fang K.C., Sheu J.Y., Hsu S.L., Tzeng C.C. Synthesis and antibacterial evaluation of certain quinolone derivatives // J. Med. Chem. 2001. V. 44. P. 2374-2377.

30. Ebisu H., Nishikawa M., Tanaka M., Okazoe T., Morizawa Y., Shinyama H., Nakamura N., Cardiovasc J. Pharmacologic profiles of GA0113, a novel quinoline derivative angiotensin II AT1-receptor antagonist // Pharmacol. 1999.

V. 34. P. 526-532.

31. Maguire M. P., Sheets K.R., McVety K., Spada A.P., Zilberstein A. A new series of PDGF receptor tyrosine kinase inhibitors: 3-substituted quinoline derivatives // J. Med. Chem. 1994. V. 37. P. 2129-2137.

32. Altenbach R. J., Liu H., Banfor P.N., Browman K.E., Fox G.B., Fryer R.M., Komater V.A., Krueger K.M., Marsh K., Miller T.R., Pan J., Pan L., Sun M., Thiffault C., Wetter J., Zhao C., Zhou D., Esbenshade T.A., Hancock A.A., Cowart M. D. Synthesis, potency, and in vivo profiles of quinoline containing histamine H3 receptor inverse agonists // J. Med. Chem. 2007. V. 50. P. 5439-5448.

33. Frotscher M., Ziegler E., Marchais-Oberwinkler S., Kruchten P., Neugebauer A., Fetzer L., Scherer C., Miller-Vieira U., Messinger J., Thole H., Hartmann R.W. Design, synthesis, and biological evaluation of (hydroxyphenyl)naphthalene and quinoline derivatives: potent and selective nonsteroidal inhibitors of 17-hydroxysteroid dehydrogenase type 1 (17-HSD1) for the treatment of estrogen-dependent diseases // J. Med. Chem. 2008. V. 51. P.

2158-2169.

34. Bilker O., Lindo V., Panico M., Etiene A.E., Paxton T., Dell A., Rogers M., Sinden, R.E., Morris H.R. Identification of xanthurenic acid as the putative inducer of malaria development in the mosquito // Nature. 1998. V. 392. P. 289-292.

35. Winstanley P.A. Chemotherapy for falciparum malaria: the armoury, the problems and the prospects // Parasitol. Today. 2000. V. 16. P. 146-153.


36. Stork G., Niu D., Fujimoto A., Koft E.R., Balkovec J.M., Tata J.R., Dake G.R. The first stereoselective total synthesis of quinine // J. Am. Chem. Soc. 2001. V. 123. P. 3239-3242.

37. Thayer A.M. New antimalarial drugs are needed to ensure that effective and affordable treatments continue to be available and are not lost to parasite resistance // Chem. Eng. News. 2005. V. 83. P. 69-82.

38. Madrid P.B., Sherrill J., Liou A.P., Weisman J.L., DeRisib J.L., Guya R.K.

Parallel synthesis of 9-aminoacridines and their evaluation against chloroquine resistant Plasmodium falciparum // Bioorg. Med. Chem. Lett. 2005. V. 15. P.

1015-1018.

39. Wiesner J., Ortmann R., Jomaa H., Schlitzer M. New antimalarial drugs // Angew. Chem. Int. Ed. 2003. V. 43. P. 5274-5293.

40. Fournet A., Vagneur B., Richomme P., Bruneton J. Aryl-2 et alkyl- quinolkines nouvelles isolkes d'une Rutacke bolivienne: Galipea longiflora // Can.

J. Chem. 1989. V. 67. P. 2116-2118.

41. Fournet A., Hocquemiller R., Roblot F., Cav A., Richomme P., Bruneton J.

Les chimanines, nouvelles quinoleines substituees en 2, isolees d'une plante bolivienne antiparasitaire: Galipea longiflora // J. Nat. Prod. 1993. V. 56. P.

1547-1552.

42. Fournet A., Barrios A.A., Muoz V., Hocquemiller R., Cav A., Richomme P., Bruneton J. 2-substituted quinoline alkaloids as potential antileishmanial drugs // J. Antimicrob. Agents Chemother. 1993. V 37. P. 859-863.

43. Wright C.W., Addae-Kyereme J., Breen A.-G., Brown J.E., Cox M.F., Croft S.L., Gkek Y., Kendrick H., Phillips R.M., Pollet P.L. Synthesis and evaluation of cryptolepine analogues for their potential as new antimalarial agents // J. Med.

Chem. 2001. V. 44. P. 3187-3194.

44. Nicolaou K.C., Gross J.L., Kerr M.A. Synthesis of novel heterocycles related to the dynemicin a ring skeleton // J. Heterocycl. Chem. 1996. V. 33. P. 735-746.

45. Bringmann G., Reichert Y., Kane V. The total synthesis of streptonigrin and related antitumor antibiotic natural products // Tetrahedron. 2004. V. 60. P.

3539-3574.

46. Chiari E., Oliveira A.B., Prado M.A.F., Alves R.J., Galvo L.M.C., Araujo F.G. Potential use of WR6026 as prophylaxis against transfusion-transmitted American trypanosomiasis // Antimicrob. Agents Chemother. 1996. V. 40. P.

613-615.

47. Sahu N.S., Pal C., Mandal N.B., Banerjee S., Raha M., Kundu A.P., Basu A., Ghosh M., Roy K., Bandyopadhyay S. Synthesis of a novel quinoline derivative, 2-(2-methylquinolin-4-ylamino)-N-phenylacetamide - a potential antileishmanial agent // Bioorg. Med. Chem. 2002. V. 10. P. 1687-1693.

48. Fang K.-C., Chen Y.-L., Sheu J.-Y., Wang T.-C., Tzeng C.-C. Synthesis, antibacterial, and cytotoxic evaluation of certain 7-substituted norfloxacin derivatives // J. Med. Chem. 2000. V. 43. P. 3809-3812.

49. Chevalier J., Atifi S., Eyraud A., Mahamoud A., Barbe J., Pages J.-M. New pyridoquinoline derivatives as potential inhibitors of the fluoroquinolone efflux pump in resistant enterobacter aerogenes strains // J. Med. Chem. 2001. V. 44.

P. 4023-4026.

50. Phan L.T., Jian T., Chen Z., Qiu Y.-L., Wang Z., Beach T., Polemeropoulos A., Or Y.S. Synthesis and antibacterial activity of a novel class of 4-substituted 16-membered ring macrolides derived from tylosin // J. Med. Chem. 2004. V.

47. P. 2965-2968.

51. Benkovic S.J., Baker S.J., Alley M.R.K., Woo Y.-H, Zhang Y.-K., Akama,T., Mao W., Baboval J., Rajagopalan P.T.R., Wall M., Kahng L.S., Tavassoli A., Shapiro L. Identification of borinic esters as inhibitors of bacterial cell growth and bacterial methyltransferases, CcrM and MenH // J. Med. Chem. 2005. V. 48. P. 7468-7476.

52. Vargas L.Y., Castelli M.V., Kouznetsov V.V., Urbina J.M., Lopez S.N., Sortino M., Enriz R.D., Ribas J.C., Zacchino S. In vitro antifungal activity of new series of homoallylamines and related compounds with inhibitory properties of the synthesis of fungal cell wall polymers // Bioorg. Med. Chem. 2003. V. 11. P.

1531-1550.

53. Singh M., Singh, M.P., Ablordeppey S.Y. In vitro studies with liposomal cryptolepine // Drug Dev. Ind. Pharm. 1996. V. 22. P. 377-381.

54. Dassonneville L., Lansiaux A., Wattelet, A., Wattez N., Mahieu, C., Van Miert S., Pieters L., Bailly C. Cytotoxicity and cell cycle effects of the plant alkaloids cryptolepine and neocryptolepine: relation to drug-induced apoptosis // Eur. J. Pharmacol. 2000. V. 409. P. 9-18.

55. Ablordeppey S.Y., Fan P., Li S., Clark A.M., Huord C.D. Substituted indoloquinolines as new antifungal agents // Bioorg. Med. Chem. 2002. V. 10.

P. 1337-1346.

56. Dassonneville L., Bonjean K., De Pauw-Gillet M.-C., Colson P., Houssier C., Quetin-Leclercq J., Angenot L., Bailly C. Stimulation of topoisomerase II mediated DNA cleavage by three DNA-intercalating plant alkaloids: cryptolepine, matadine, and serpentine // Biochemistry 1999. V. 38. P. 7719-7726.

57. Bailly C., Laine W., Baldeyrou B.. De Pauw-Gillet M.-C., Colson P., Houssier C., Cimanga K., Miert S.V., Vlietinck A.J., Pieters L. DNA intercalation, topoisomerase II inhibition and cytotoxic activity of the plant alkaloid neocryptolepine // Anti-Cancer Drug Des. 2000. V. 15. P. 191-201.

58. Jones G. Comprehensive Heterocyclic Chemistry II // Pergamon: Oxford. 1996. V. 5. P. 167-243.

59. Holla B.S., Mahalinga M., Karthikeyan M.S., Akberalib P.M., Shettyc N.S.

Synthesis of some novel pyrazolo[3,4-d]pyrimidine derivatives as potential antimicrobial agents // Bioorg. Med. Chem. 2006. V. 14. P. 2040-2047.

60. .., .., .., ..

// .

. 1973. V. 15. P. 740-748.

61. Caus S., Gondek E., Danel A., Jarosz B., Pokadko M., Kityk A.V.

Electroluminescence of 6-R-1,3-diphenyl-1H-pyrazolo[3,4-b] quinoline-based organic light-emitting diodes (R = F, Br, Cl, CH3, C2H3 and N(C6H5)2) // Mater.

Lett. 2007. V. 61. P. 3292-3295.

62. Caeiro G., Lopes J.M., Magnoux P., Ayrault P., Ribeiro F.R. A FT-IR study of deactivation phenomena during methylcyclohexane transformation on H-USY zeolites: Nitrogen poisoning, coke formation, and acidity-activity correlations // J.

Catal. 2007. V. 249. P. 234-243.

63. Du W., Curran D.P. Synthesis of carbocyclic and heterocyclic fused quinolines by cascade radical annulations of unsaturated N-aryl thiocarbamates, thioamides, and thioureas // Org. Lett. 2003. V. 5. P. 1765-1768.

64. Hoemman M.Z., Kumaravel G., Xie R.L., Rossi R.F., Meyer S., Sidhu A., Cuny G.D., Hauske J.R. Potent In vitro methicillin-resistant Staphylococcus aureus activity of 2-(1H-indol-3-yl)quinoline derivatives // Bioorg. Med. Chem. Lett. 2000. V. 10. P. 2675-2678.

65. . . . .

. . . 2006. 456 .

66. Cheng C.-C., Yan S.-J. The Friedlnder synthesis of quinolines // Org.

React. 1982. V. 28. P. 37-201.

67. Jones G. In The Chemistry of Heterocyclic Compounds // John Wiley and Sons: Chichester. 1977. V. 32. P. 93-318.

68. Niementowski S.V. Synthesen der Chinolinderivate // Ber. Dtsch. Chem.

Ges. 1894. V. 27. P. 1394-1403.

69. Manske R.H. The Chemistry of Quinolines // Chem. Rev. 1942. V. 30. P. 113-144.

70. Borsche W., Ried W. Chinolinsynthese mit 2-Amino-benzal-4-toluidinen // Justus Liebigs Ann. Chem. 1943. V. 554. P. 269-290.

71. Reitsema R.H. The Chemistry of 4-Hydroxyquinolines. // Chem. Rev. 1948. V. 43. P. 47-68.

72. Gabriele B., Mancuso R., Salerno G., Ruffolo G., Plastina P. Novel and convenient synthesis of substituted quinolines by copper- or palladium-catalyzed cyclodehydration of 1-(2-aminoaryl)-2-yn-1-ols // J. Org. Chem. 2007. V.72. P. 6873-6877.

73. Sandelier M.J. DeShong P. Reductive cyclization of o-nitrophenyl propargyl alcohols: facile synthesis of substituted quinolines // Org. Lett. 2007. V. 9. P.

3209-3212.

74. Jones C.P., Anderson K.W., Buchwald S.L. Sequential Cu-catalyzed amidation-base-mediated camps cyclization: a two-step synthesis of 2-aryl-4 quinolones from o-halophenones // J. Org. Chem. 2007. V. 72. P. 7968-7973.

75. Ali S., Zhu H., Xia X., Ji K., Yang Y., Song X., Yang Y.M. Electrophile driven regioselective synthesis of functionalized quinolines // Org. Lett. 2011. V. 13. P. 2598-2601.

76. Tokunaga M., Eckert M. Wakatsuki Y. Ruthenium-catalyzed intermolecular hydroamination of terminal alkynes with anilines: a practical synthesis of aromatic ketimines // Angew. Chem., Int. Ed. 1999. V. 38. P. 3222-3225.

77. Bortolotti B., Leardini R., Nanni D., Zanardi G. DDQ-mediated formation of carbon-carbon bonds: oxidation of imines // Tetrahedron. 1993. V. 49. P.

10157-10174.

78. Collin J., Jaber N., Lannou M. I. Imino-DielsAlder and imino-aldol reactions catalyzed by samarium diiodide // Tetrahedron Lett. 2001. V. 42. P.

7405-7407.

79. Leardini R., Nanni D., Tundo A., Zanardi G., Ruggieri F. Annulation reactions with iron(III) chloride: oxidation of imines // J. Org. Chem. 1992. V.

57. P. 1842-1848.

80. Majimdar K.C., Debnath P., De N., Roy B. Metal-catalyzed Heterocyclization: Synthesis of five- and six-membered nitrogen heterocycles through carbon-nitrogen bond forming reactions // Curr. Org. Lett. 2011. V. 15.

P. 1760-1801.

81. Brunet J.-J., Chu N.-C., Rodriguez-Zubiri M. Platinum-catalyzed intermolecular hydroamination of alkenes: halide-anion-promoted catalysis // Eur.

J. Inorg. Chem. 2007. 4711-4722.

82. Madapa S., Tusi Z., Batra S. Advances in the syntheses of quinoline and quinoline-annulated ring systems // Current Org. Chem. 2008. V. 12. P.

1116-1183.

83. Tsuji J. Palladium Reagents and Catalysts: Innovations in Organic Synthesis.

Wiley: Chichester. 1995. 560 p.

84. Murahashi S.-I. Ruthenium in Organic Synthesis, Wiley-VCH. 2004. p.

85. .., .., .. . .: . 2003. 303 c.

86. ., . , ., . 2004. 728 c.

87. Friedlander P. Ueber o-aminobenzaldehyd // Ber. Dtsch. Chem. Ges. 1882.

V. 15. P. 2572-2575.

88. Wang G.-W., Jia C.-S., Dong Y.-W. Benign and highly efficient synthesis of quinolines from 2-aminoarylketone or 2-aminoarylaldehyde and carbonyl compounds mediated by hydrochloric acid in water // Tetrahedron Lett. 2006. V. 47. 7. P. 1059-1063.

89. Selvam N.P., Saravanan C., Muralidharan D., Perumal P.T. Water mediated synthesis of substituted quinolines A new green approach to the Friedlander annulation // J. Heterocyclic Chem. 2006. V. 43. P. 1379-1382.

90. Muscia G.C., Bollini M., Carnevale J.P., Bruno A.M., Asis S.E. Microwave assisted Friedlander synthesis of quinolines derivatives as potential antiparasitic agents // Tetrahedron Lett. 2006. V. 47. Issue 50. P. 8811-8815.

91. Jia C.-S., Zhang Z., Tu S.-J., Wang G.-W. Rapid and efcient synthesis of poly-substituted quinolines assisted by p-toluene sulphonic acid under solvent-free conditions: comparative study of microwave irradiation versus conventional heating // Org. Biomiol. Chem. 2006. V. 4. P. 104-110.

92. Yadav J.S., Rao P.P., Sreenu D., Rao R.S., Kumar V.N., Nagaiah K., Prasad A.R. Sulfamic acid: an ecient, cost-eective and recyclable solid acid catalyst for the Friedlander quinoline synthesis // Tetrahedron Lett. 2005. V. 46. Issue 49. P. 7249-7253.

93. Wu J., Xia, H.-G., Gao K. Molecular iodine: a highly efcient catalyst in the synthesis of quinolines via Friedlander annulation // Org. Biomol. Chem. 2006. V. 4. P. 126-129.

94. Narasimhulu M., Reddy T.S., Mahesh K.C., Prabhakar P., Rao Ch.B., Venkateswarlu Y. Silica supported perchloric acid: A mild and highly efcient heterogeneous catalyst for the synthesis of poly-substituted quinolines via Friedlander hetero-annulation // J Mol. Catal. A: Chem. 2007. V. 266. P. 114 117.

95. Das B., Damodar K., Chowdhury N., Kumar R.A. Application of heterogeneous solid acid catalysts for Friedlander synthesis of quinolines // J. Mol.

Catal. A: Chem. 2007. V. 274. P. 148-152.

96. Arumugam P., Karthikeyan G., Atchudan R., Muralidharan D., Perumal P.T.

A simple, ecient and solvent-free protocol for the Friedlander synthesis of quinolines by using SnCl22H2O // Chem. Lett. 2005. V. 34. P. 314-315.

97. De S.K., Gibbs R.A. A mild and ecient one-step synthesis of quinolines // Tetrahedron Lett. 2005. V. 46. Issue 10. P. 1647-1649.

98. Wu J., Zhang L., Diao T. An expeditious approach to quinolines via Friedlnder synthesis catalyzed by FeCl3 or Mg(ClO4)2 // Synlett. 2005. P.

2653-2657.

99. Kumar S., Saini A., Sandhu J.S. Iron(III) ChloridePromoted, SolventFree, Facile, and Efficient Friedlnder Synthesis of Quinolines // Synth. Commun. 2007. V. 37. P. 4071-4078.

100. Bose D.S., Kumar R.K. An efficient, high yielding protocol for the synthesis of functionalized quinolines via the tandem addition/annulation reaction of o-aminoarylketones with -methylene ketones // Tetrahedron Lett. 2006. V.

47. Issue 5. P. 813-816.

101. Varala R., Enugala R., Adapa S.R. Efficient and rapid Friedlander synthesis of functionalized quinolines catalyzed by neodymium (III) nitrate hexahydrate // Synthesis. 2006. P. 3825-3830.

102. Ryabukhin S.V., Volochnyuk D.M., Plaskon A.S., Naumchik V.S., Friedlnder synthesis of Tolmachev A.A. Chlorotrimethylsilane-mediated polysubstituted quinolines // Synthesis. 2007. Issue 8. P. 1214-1224.

103. Degtyarenko A.S., Tolmachev A.A., Volovenko Y.M., Tverdokhlebov A.V. Chlorotrimethylsilane-mediated Friedlnder synthesis of 2-(-chloroalkyl) quinoline derivatives // Synthesis. 2007. Issue 24. P. 3891-3895.

104. Zolfigol M.A. Salehi P., Ghaderi A., Shiri M. A catalytic and green procedure for Friedlander quinoline synthesis in aqueous media // Catal. Commun.

- 2007. - V. 8. - P. 1214-1218.

105. Zhang L., Wu, J. Friedlander synthesis of quinolines using a Lewis acid-surfactant-combined catalyst in water // Adv. Synth. Catal. 2007. V. 349.

P. 1047-1051.

106. Atechian S., Nock N., Norcross R.D., Ratni H., Thomas A.W., Verron J., Masciadri R. New vistas in quinoline synthesis // Tetrahedron. 2007. V. 63.

P. 2811-2823.

107. Liu X,-Y., Ding P., Huang J.-S., Che C.-M. Synthesis of substituted 1,2-dihydroquinolines and quinolines from aromatic amines and alkynes by gold(I)-catalyzed tandem hydroamination hydroarylation under microwave assisted conditions // Org. Lett. 2007. V. 9. P. 2645-2648.

108. Lekhok K.C., Prajapati D., Boruah R.C. Indium (III) trifluoromethanesulfonate: an efficient reusable catalyst for the alkynylation cyclization of 2-aminoaryl ketones and synthesis of 2,4-disubstituted quinolines // Synlett. 2008. 5. P. 655-658.

109. Chelucci G., Manca I., Pinna G. Synthesis of regiospecically substituted quinolines from anilines // Tetrahedron Lett. 2005. V. 46. Issue 5.

- P. 767-770.

110. Yang D., Jiang K., Li J., Xu F. Synthesis and characterization of quinoline derivatives via the Friedlander reaction // Tetrahedron. 2007. V. 63. Issue 32. P. 7654-7658.

111. Kalai T., Bognar B., Jeko J., Hideg K. Synthesis of new, paramagnetically modified heterocycles // Synthesis. 2006. V. 15. P. 2573 2579.

112. Cho C.S., Ren W.X., Shim S.C. Synthesis of quinolines via Pd/C catalyzed cyclization of 2-aminobenzyl alcohol with ketones // Bull. Korean Chem.

Soc. 2005. V. 26. 8. P. 1286-1288.

113. Cho C.S., Ren W.X., Shim S.C. Ruthenium-catalyzed synthesis of 3 substituted quinolines from 2-aminobenzyl alcohol and aldehydes // Bull. Korean Chem. Soc. 2005. V. 26. 12. P. 2038-2040.

114. Cho C.S., Kim B.T., Choi H.-J., Kim T.-J., Shim S.C. Ruthenium catalyzed oxidative coupling and cyclization between 2-aminobenzyl alcohol and secondary alcohols leading to quinolines // Tetrahedron. 2003. V. 59. P.

7997-8002.

115. Cho C.S., Seok H.J., Shim S.C. Ruthenium-catalysed oxidative cyclisation of 2-aminobenzyl alcohol with ketones: modified Friedlaender quinoline synthesis // Chem. Comunn. 2001. P. 2576-2577.

116. Cho C.S., Seok H.J., Shim S.C. A Rhodium-catalyzed route for oxidative coupling and cyclization of 2-aminobenzyl alcohol with ketones leading to quinolines // J. Heterocyclic. Chem. 2005. V. 42. P. 1219-1222.

117. Cho C.S. Ren W.X., Shim S.C. A copper (II)-catalyzed protocol for modied Friedlander quinoline synthesis // Tetrahedron Lett. 2006. V. 47. Issue 38. P. 6781-6785.

118. Taguchi K., Sagaguchi S., Ishii Y. Synthesis of quinolines from amino alcohol and ketones catalyzed by [IrCl(cod)]2 or IrCl3 under solvent-free conditions // Tetrahedron Lett. 2005. V 46. Issue 27. P. 4539-4542.

119. Mierde H.V., Ledoux N., Allaert B., Voort P.V., Drozdzak R., Vos D., Verpoort F. Improved ruthenium catalysts for the modified Friedlaender quinoline synthesis // New. J. Chem. 2007. V. 31. P. 1572-1574.

120. Martinez R., Ramon D.J.,Yus M. RuCl2(dmso)4 Catalyzes the solvent free indirect Friedlnder synthesis of polysubstituted quinolines from alcohols // Eur. J. Org. Chem. 2007. P. 1599-1605.

121. Wu Y.-C., Liu L., Li H.-J., Wang D., Chen Y.-J. Skraup-Doebner-Von Miller quinoline synthesis revisited: reversal of the regiochemistry for -aryl-, unsaturated -ketoesters // J. Org. Chem. - 2006. V. 71. P. 6592-6595.

122. Jain M., Khan S.I., Tekwani B.L., Jacob M.R., Singh S., Singh P.P., Jain R. Synthesis, antimalarial, antileishmanial, and antimicrobial activities of some 8-quinolinamine analogues // Bioorg. Med. Chem. 2005. V. 13. P.

4458-4466.

123. Jain R., Jain S., Gupta R.C., Anand N., Dutta G.P., Puri S.K.

Synthesis of amino acid derivatives of 8-(4-amino-1-methylbutyl)amino-6 methoxy-4-substituted, 5-disubstituted quinolines as potential antimalarial agents // Indian J. Chem. 1994. V. 33B. P. 251-254.

124. Carroll F.I., Berrang B., Linn C.P. 4-Substituted 5-[m (trifluoromethyl)phenoxy]primaquine analogues as Potential antimalarial agents // J. Med. Chem. 1985. V. 28. P. 1564-1567.

125. Shivaprasad G., Rajesh R., Perumal P.T. Synthesis of quinaldines and lepidines by a DoebnerMiller reaction under thermal and microwave irradiation conditions using phosphotungstic acid // Tetrahedron Lett. 2006. V. 47. Issue 11. P. 1783-1785.

126. Musiol R., Jampilek J., Kralova K., Richardson D.R., Kalinowski D., Podeszwa B., Finster J., Niedbala H., Palka A., Polanski J. Investigating biological activity spectrum for novel quinoline analogues // Bioorg. Med. Chem. 2007. V. 15. P. 1280-1288.

Polanski J., Zouhiri F., Jeanson L., Desmaele D., dAngelo J., 127.

Mouscadet J., Gieleciak R., Gasteiger J., Bret M.L. Use of the kohonen neural network for rapid screening of ex vivo anti-HIV activity of styrylquinolines // J.

Med. Chem. 2002. V. 45. P. 4647-4654.



Pages:     | 1 | 2 || 4 |
 
 >>  ()





 
<<     |    
2013 www.libed.ru - -

, .
, , , , 1-2 .